IGC Pharma Inc/ US45408X3089 /
2024-04-25 9:39:22 PM | Chg. -0.0053 | Volume | Bid9:40:00 PM | Ask9:40:00 PM | High | Low |
---|---|---|---|---|---|---|
0.4337USD | -1.21% | 221,832 Turnover: 83,086.5402 |
0.4206Bid Size: 300 | 0.4337Ask Size: 200 | 0.4479 | 0.4170 |
GlobeNewswire
2018-03-26
Puerto Rican Alzheimer’s Patients to Be First in U.S. to Obtain Cannabis-Based Relief
GlobeNewswire
2018-03-12
India Globalization Capital Appoints Carrolee Barlow, MD, PhD as Advisor to Help Develop Cannabis Re...
GlobeNewswire
2018-03-01
India Globalization Capital Partners with Parkinson’s Institute and Clinical Center to Develop Canna...
GlobeNewswire
2018-02-20
IGC Announces Third Quarter Financial Results Advances Hyalolex to Commercialization Stage
GlobeNewswire
2018-02-12
India Globalization Capital’s CEO to Speak at CEO Healthcare Symposium in NY on February 12 & 13
GlobeNewswire
2018-02-08
Ram Mukunda, CEO of India Globalization Capital, Inc., Joins Everett Jolly on Uptick Newswire’s “Sto...
GlobeNewswire
2018-01-02
India Globalization Capital Reports Promising Spatial Memory Results in Alzheimer’s Study
GlobeNewswire
2017-12-26
India Globalization Capital to use Blockchain to Address Issues Specific to the Medical Cannabis Ind...
GlobeNewswire
2017-12-18
IGC Announces Adjournment of Annual Meeting Voting for Proposals Three and Four to Dec 29, 2017
GlobeNewswire
2017-12-14
India Globalization Capital Provides Update on Hyalolex for Alzheimer’s Commercialization Strategy
GlobeNewswire
2017-12-07
India Globalization Capital Launches New Corporate Websites Highlighting Canna-Pharmaceutical Compou...
GlobeNewswire
2017-11-22
IGC Announces Adjournment of Annual Meeting Voting for Proposals Three and Four to Dec 15, 2017
GlobeNewswire
2017-11-20
India Globalization Capital Reports Second Quarter 2018 Financial Results and Operational Highlights
GlobeNewswire
2017-10-18
IGC-AD1 Targeting Alzheimer’s Disease to be commercialized in early 2018 Through Medical Dispensarie...
GlobeNewswire
2017-10-04
IGC Prepares a Liquid Delivery Formulation of IGC-AD1 for Alzheimer’s Based on Novel In Vitro Data
GlobeNewswire
2017-09-18
IGC Readies Line of Medical Dispensary Products Targeting Alzheimer’s Disease Based on Novel Data